How to configure the different clinical compound numbers in the study?
(Doc ID 1671633.1)
Last updated on DECEMBER 05, 2019
Applies to:Oracle Argus Safety Japan - Version 7.0.2 and later
Information in this document applies to any platform.
How to configure the different clinical compound numbers in a study?
We need to submit separate E2B (R2) reports to PMDA when the different ingredients (clinical compound numbers) are registered in one study.
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document